These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21466494)

  • 1. Methotrexate: a drug of the future in ulcerative colitis?
    Carbonnel F
    Curr Drug Targets; 2011 Sep; 12(10):1413-6. PubMed ID: 21466494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of methotrexate in ulcerative colitis: failure or promise.
    Herfarth HH; Osterman MT; Isaacs KL; Lewis JD; Sands BE
    Inflamm Bowel Dis; 2010 Aug; 16(8):1421-30. PubMed ID: 20186931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis.
    Carbonnel F; Colombel JF; Filippi J; Katsanos KH; Peyrin-Biroulet L; Allez M; Nachury M; Novacek G; Danese S; Abitbol V; Bossa F; Moreau J; Bommelaer G; Bourreille A; Fumery M; Roblin X; Reinisch W; Bouhnik Y; Brixi H; Seksik P; Malamut G; Färkkilä M; Coulibaly B; Dewit O; Louis E; Deplanque D; Michetti P; Sarter H; Laharie D; ;
    Gastroenterology; 2016 Feb; 150(2):380-8.e4. PubMed ID: 26632520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of infliximab use in ulcerative colitis.
    Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
    Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate for induction of remission in ulcerative colitis.
    Chande N; MacDonald JK; McDonald JW
    Cochrane Database Syst Rev; 2007 Oct; (4):CD006618. PubMed ID: 17943916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate: should we start using it in clinical practice?
    Miheller P; Kiss LS; Mandel M; Lakatos PL
    Curr Drug Targets; 2013 Nov; 14(12):1480-9. PubMed ID: 23651163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate for maintenance of remission in ulcerative colitis.
    El-Matary W; Vandermeer B; Griffiths AM
    Cochrane Database Syst Rev; 2009 Jul; (3):CD007560. PubMed ID: 19588435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.
    Chande N; McDonald JW; Macdonald JK
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006774. PubMed ID: 18425969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumour necrosis factor therapy for ulcerative colitis: evidence to date.
    Thukral C; Cheifetz A; Peppercorn MA
    Drugs; 2006; 66(16):2059-65. PubMed ID: 17112300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.
    Sandborn WJ; Feagan BG; Marano C; Zhang H; Strauss R; Johanns J; Adedokun OJ; Guzzo C; Colombel JF; Reinisch W; Gibson PR; Collins J; Järnerot G; Hibi T; Rutgeerts P;
    Gastroenterology; 2014 Jan; 146(1):85-95; quiz e14-5. PubMed ID: 23735746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with the use of low-dose methotrexate for inflammatory bowel disease.
    Soon SY; Ansari A; Yaneza M; Raoof S; Hirst J; Sanderson JD
    Eur J Gastroenterol Hepatol; 2004 Sep; 16(9):921-6. PubMed ID: 15316419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral methotrexate in ulcerative colitis.
    Cummings JR; Herrlinger KR; Travis SP; Gorard DA; McIntyre AS; Jewell DP
    Aliment Pharmacol Ther; 2005 Feb; 21(4):385-9. PubMed ID: 15709988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease.
    Kozarek RA; Patterson DJ; Gelfand MD; Botoman VA; Ball TJ; Wilske KR
    Ann Intern Med; 1989 Mar; 110(5):353-6. PubMed ID: 2492786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of methotrexate in an inflammatory bowel diseases based on the review of the current literature].
    Klimczak K; Łykowska-Szuber L; Krela-Kaźmierczak I; Eder P; Szymczak A; Stawczyk-Eder K; Linke K
    Wiad Lek; 2016; 69(2 Pt 2):262-6. PubMed ID: 27487545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.
    Damião AOMC; de Azevedo MFC; Carlos AS; Wada MY; Silva TVM; Feitosa FC
    World J Gastroenterol; 2019 Mar; 25(9):1142-1157. PubMed ID: 30863001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of infliximab in ulcerative colitis].
    Tilg H; Feichtenschlager T; Knoflach P; Petritsch W; Schöfl R; Vogelsang H; Reinisch W
    Z Gastroenterol; 2007 Aug; 45(8):907-11. PubMed ID: 17701864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there room for immunomodulators in ulcerative colitis?
    Chhibba T; Ma C
    Expert Opin Biol Ther; 2020 Apr; 20(4):379-390. PubMed ID: 31874578
    [No Abstract]   [Full Text] [Related]  

  • 20. Adalimumab in ulcerative colitis: hypes and hopes.
    Fiorino G; Peyrin-Biroulet L; Repici A; Malesci A; Danese S
    Expert Opin Biol Ther; 2011 Jan; 11(1):109-16. PubMed ID: 21133817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.